#Santé #Pharma #FDA approves Sunovion Latuda treat some cases of bipolar disorder http://t.co/l0fMGK6RlF Le monde est fou (DSM5) à #Méditer
July 04, 2013
/http%3A%2F%2Fc.o0bc.com%2Frw%2FSysConfig%2FWebPortal%2FBoston%2FFramework%2Fimages%2Fsite_graphics%2Ficons%2Fshare%2Fbcom_og_news.gif)
FDA approves Sunovion's Latuda to treat some cases of bipolar disorder
Sunovion Pharmaceuticals Inc., a Marlborough drug company owned by Dainippon Sumitomo Pharma Co. of Japan, said that it has received regulatory approval to market its Latuda drug for additional uses in the United States. Latuda was initially approved the Food and Drug Administration as a treatment for adults with schizophrenia in 2010 and launched in 2011.